HAMILTON, ON and BOSTON, June 4, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), announced the ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook According to those who spoke to Insider Gaming, staffers were encouraged to take their holiday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results